Aker BP ASA (AKRBP)
Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 386.00 |
|---|---|
| 52-week range | 240.60 – 394.80 |
| Return, 1 month / 3 months | +10.7% / +16.2% |
| Return, 1 year / 3 years | +58.6% / +66.0% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 34.1% |
| Worst drawdown (1 year) | -17.7% |
| Average daily value traded | 325.57M NOK |
| Dividend yield | 6.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aker BP is an independent oil and gas company based in Norway that explores for and produces petroleum on the Norwegian Continental Shelf. Its operations centre on a set of offshore fields and installations, including the Alvheim, Ivar Aasen, Skarv and Valhall areas, where it produces crude oil, natural gas and natural gas liquids. The company supplies these hydrocarbons to energy markets, and it also works on field development projects and on reducing emissions from its offshore activities.
Aker BP ASA trades under the code AKRBP on the Oslo Børs in Norway, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aker BP ASA (AKRBP) trades on the Oslo Børs in Norway. It last closed at NOK 386.00 on 27 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 15 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 58.6% and over the last three months it rose 16.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.5% | ||
| From 52-week high | -1.8% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 16.2% | ||
| 6-month return | 14.4% | ||
| 12-month return, skipping the last month | 43.2% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.7% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 325.57M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | +10.7% |
| 3 months | +16.2% |
| 6 months | +14.4% |
| 1 year | +58.6% |
| 3 years | +66.0% |
| 5 years | +75.0% |
Signals
| 50-day / 200-day average | 358.77 / 323.03 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Jul 2026 | NOK 6.4259 |
| 12 May 2026 | NOK 6.1285 |
| 16 Feb 2026 | NOK 6.2942 |
| 27 Oct 2025 | NOK 6.3319 |
| 18 Jul 2025 | NOK 6.3619 |
| 12 May 2025 | NOK 6.5174 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.